SEER
Seer, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.89
−1.82%Price chart
Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15Sep 18
Key dataSep 18, 2026
Open$1.88
From 52W high−20.46%
Volume256257.00
Market cap$104.38M
P/E (TTM)—
P/S (TTM)7.5x
Div yield—
Key dataSep 18, 2026
Open
$1.88
From 52W high
−20.46%
Volume
256257.00
Market cap
$104.38M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
0.4x
P/E (TTM)
—
RSI (14)
37.5
MomentumView details →
1D Return
−1.82%
YTD Return
+4.10%
SummaryUpdated Jun 1, 2026
Seer, Inc. (NASDAQ:SEER) is a life sciences company founded in 2017 and headquartered in Redwood City, California. The company went public in December 2020 and specializes in developing and commercializing advanced proteomics technology to help researchers decode the complexities of the human proteome. Seer has positioned itself as a pioneer in deep, unbiased proteomics analysis at scale, serving over 135 customers across 20 countries through its flagship Proteograph Product Suite.
Similar companies
Latest newsMore news →
David Horn resigned as President, Chief Financial Officer and Treasurer of Seer, Inc., effective October 1, 2026.2d agoSeer, Inc. appointed Charles Endweiss as Treasurer and principal financial and accounting officer, effective October 1, 2026.2d agoSeer, Inc. appointed Omid Farokhzad as President, effective October 1, 2026.2d ago